Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases
Condition(s):Brain Metastases; Radiotherapy; EGFR Activating MutationLast Updated:March 14, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Brain Metastases; Radiotherapy; EGFR Activating MutationLast Updated:March 14, 2023Recruiting
Condition(s):Advanced Solid TumorsLast Updated:March 14, 2023Recruiting
Condition(s):Transesophageal Echocardiography; Acute Respiratory Distress Syndrome; Right Ventricular DysfunctionLast Updated:March 14, 2023Not yet recruiting
Condition(s):High Myopia; Axial Length; Eye DiseasesLast Updated:March 14, 2023Not yet recruiting
Condition(s):Invasive Breast CancerLast Updated:March 14, 2023Not yet recruiting
Condition(s):SarcopeniaLast Updated:March 14, 2023Recruiting
Condition(s):Muscle-Invasive Bladder CarcinomaLast Updated:March 14, 2023Recruiting
Condition(s):Cervical Spinal StenosisLast Updated:March 14, 2023Recruiting
Condition(s):Parkinson DiseaseLast Updated:March 14, 2023Recruiting
Condition(s):Acute Respiratory Distress SyndromeLast Updated:March 14, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.